Literature DB >> 20189798

The effects of radiofrequency ablation on the hepatic parenchyma: histological bases for tumor recurrences.

G Gravante1, S L Ong, M S Metcalfe, N Bhardwaj, D M Lloyd, A R Dennison.   

Abstract

BACKGROUND: This review examines histological modifications obtained after liver radiofrequency ablation (RFA).
METHODS: A literature search has been undertaken for all pre-clinical and clinical studies involving RFA and in which ablation zones have been excised for a complete histological examination.
RESULTS: Two main histological areas are present, a central zone of coagulative necrosis and a peripheral rim of congestion and extravasation. Both corresponded to specific microscopic characteristics that evolved over time and that are influenced by the proximity of patent vessels and the liver perfusion status. Viable cells are not present in the central zone but have been described in the ischemic peripheral rim where they survive the ischemia and inflammation process. These correspond in clinical studies to residual viable tumor cells that lead to failure of the procedure.
CONCLUSIONS: Histological changes following RFA are complex and interactions take place at both a cellular and tissue level. Changes in the peripheral zone must be considered in future studies in order to extend the volume of reliable tumor destruction and increase the effectiveness of the procedure.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20189798     DOI: 10.1016/j.suronc.2010.01.005

Source DB:  PubMed          Journal:  Surg Oncol        ISSN: 0960-7404            Impact factor:   3.279


  5 in total

Review 1.  Radiofrequency ablation versus resection for liver tumours: an evidence-based approach to retrospective comparative studies.

Authors:  Gianpiero Gravante; John Overton; Roberto Sorge; Neil Bhardwaj; Matthew S Metcalfe; David M Lloyd; Ashley R Dennison
Journal:  J Gastrointest Surg       Date:  2011-02       Impact factor: 3.452

2.  Patterns of histological changes following hepatic electrolytic ablation in an ex-vivo perfused model.

Authors:  Gianpiero Gravante; Seok Ling Ong; Kevin West; Angus McGregor; Guy J Maddern; Matthew S Metcalfe; David M Lloyd; Ashley R Dennison
Journal:  Pathol Oncol Res       Date:  2012-06-17       Impact factor: 3.201

3.  Echo Decorrelation Imaging of Rabbit Liver and VX2 Tumor during In Vivo Ultrasound Ablation.

Authors:  Tyler R Fosnight; Fong Ming Hooi; Ryan D Keil; Alexander P Ross; Swetha Subramanian; Teckla G Akinyi; Jakob K Killin; Peter G Barthe; Steven M Rudich; Syed A Ahmad; Marepalli B Rao; T Douglas Mast
Journal:  Ultrasound Med Biol       Date:  2016-10-04       Impact factor: 2.998

4.  Interactive registration of 2D histology and 3D CT data for assessment of radiofrequency ablation treatment.

Authors:  Matthias Seise; Tuomas Alhonnoro; Marina Kolesnik
Journal:  J Pathol Inform       Date:  2012-01-19

Review 5.  Advantages and Limitations of Focal Liver Lesion Assessment with Ultrasound Contrast Agents: Comments on the European Federation of Societies for Ultrasound in Medicine and Biology (EFSUMB) Guidelines.

Authors:  Liliana Chiorean; Claudio Tana; Barbara Braden; Cosmin Caraiani; Zeno Sparchez; Xin-Wu Cui; Ulrich Baum; Christoph F Dietrich
Journal:  Med Princ Pract       Date:  2016-06-17       Impact factor: 1.927

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.